Hdl Handle:
http://hdl.handle.net/10675.2/602
Title:
Intratumoral Convergence of the TCR Repertoires of Effector and Foxp3+ CD4+ T cells
Authors:
Kuczma, Michal; Kopij, Magdalena; Pawlikowska, Iwona; Wang, Cong-Yi; Rempala, Grzegorz A.; Kraj, Piotr
Abstract:
The presence of Foxp3+ regulatory CD4+ T cells in tumor lesions is considered one of the major causes of ineffective immune response in cancer. It is not clear whether intratumoral Treg cells represent Treg cells pre-existing in healthy mice, or arise from tumor-specific effector CD4+ T cells and thus representing adaptive Treg cells. The generation of Treg population in tumors could be further complicated by recent evidence showing that both in humans and mice the peripheral population of Treg cells is heterogenous and consists of subsets which may differentially respond to tumor-derived antigens. We have studied Treg cells in cancer in experimental mice that express naturally selected, polyclonal repertoire of CD4+ T cells and which preserve the heterogeneity of the Treg population. The majority of Treg cells present in healthy mice maintained a stable suppressor phenotype, expressed high level of Foxp3 and an exclusive set of TCRs not used by naive CD4+ T cells. A small Treg subset, utilized TCRs shared with effector T cells and expressed a lower level of Foxp3. We show that response to tumor-derived antigens induced efficient clonal recruitment and expansion of antigen-specific effector and Treg cells. However, the population of Treg cells in tumors was dominated by cells expressing TCRs shared with effector CD4+ T cells. In contrast, Treg cells expressing an exclusive set of TCRs, that dominate in healthy mice, accounted for only a small fraction of all Treg cells in tumor lesions. Our results suggest that the Treg repertoire in tumors is generated by conversion of effector CD4+ T cells or expansion of a minor subset of Treg cells. In conclusion, successful cancer immunotherapy may depend on the ability to block upregulation of Foxp3 in effector CD4+ T cells and/or selectively inhibiting the expansion of a minor Treg subset.
Citation:
PLoS One. 2010 Oct 26; 5(10):e13623
Issue Date:
26-Oct-2010
URI:
http://hdl.handle.net/10675.2/602
DOI:
10.1371/journal.pone.0013623
PubMed ID:
21049016
PubMed Central ID:
PMC2964305
Type:
Article
ISSN:
1932-6203
Appears in Collections:
Center for Biotechnology and Genomic Medicine: Faculty Research and Presentations

Full metadata record

DC FieldValue Language
dc.contributor.authorKuczma, Michalen_US
dc.contributor.authorKopij, Magdalenaen_US
dc.contributor.authorPawlikowska, Iwonaen_US
dc.contributor.authorWang, Cong-Yien_US
dc.contributor.authorRempala, Grzegorz A.en_US
dc.contributor.authorKraj, Piotren_US
dc.date.accessioned2012-10-26T16:26:51Z-
dc.date.available2012-10-26T16:26:51Z-
dc.date.issued2010-10-26en_US
dc.identifier.citationPLoS One. 2010 Oct 26; 5(10):e13623en_US
dc.identifier.issn1932-6203en_US
dc.identifier.pmid21049016en_US
dc.identifier.doi10.1371/journal.pone.0013623en_US
dc.identifier.urihttp://hdl.handle.net/10675.2/602-
dc.description.abstractThe presence of Foxp3+ regulatory CD4+ T cells in tumor lesions is considered one of the major causes of ineffective immune response in cancer. It is not clear whether intratumoral Treg cells represent Treg cells pre-existing in healthy mice, or arise from tumor-specific effector CD4+ T cells and thus representing adaptive Treg cells. The generation of Treg population in tumors could be further complicated by recent evidence showing that both in humans and mice the peripheral population of Treg cells is heterogenous and consists of subsets which may differentially respond to tumor-derived antigens. We have studied Treg cells in cancer in experimental mice that express naturally selected, polyclonal repertoire of CD4+ T cells and which preserve the heterogeneity of the Treg population. The majority of Treg cells present in healthy mice maintained a stable suppressor phenotype, expressed high level of Foxp3 and an exclusive set of TCRs not used by naive CD4+ T cells. A small Treg subset, utilized TCRs shared with effector T cells and expressed a lower level of Foxp3. We show that response to tumor-derived antigens induced efficient clonal recruitment and expansion of antigen-specific effector and Treg cells. However, the population of Treg cells in tumors was dominated by cells expressing TCRs shared with effector CD4+ T cells. In contrast, Treg cells expressing an exclusive set of TCRs, that dominate in healthy mice, accounted for only a small fraction of all Treg cells in tumor lesions. Our results suggest that the Treg repertoire in tumors is generated by conversion of effector CD4+ T cells or expansion of a minor subset of Treg cells. In conclusion, successful cancer immunotherapy may depend on the ability to block upregulation of Foxp3 in effector CD4+ T cells and/or selectively inhibiting the expansion of a minor Treg subset.en_US
dc.rightsKuczma et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.en_US
dc.subjectResearch Articleen_US
dc.subjectImmunology/Immune Responseen_US
dc.subjectImmunology/Immunomodulationen_US
dc.subjectImmunology/Leukocyte Activationen_US
dc.subject.meshAmino Acid Sequenceen_US
dc.subject.meshAnimalsen_US
dc.subject.meshBase Sequenceen_US
dc.subject.meshCD4-Positive T-Lymphocytesen_US
dc.subject.meshCell Separationen_US
dc.subject.meshClone Cellsen_US
dc.subject.meshDNA Primersen_US
dc.subject.meshFlow Cytometryen_US
dc.subject.meshForkhead Transcription Factorsen_US
dc.subject.meshMelanoma, Experimentalen_US
dc.subject.meshMiceen_US
dc.subject.meshMice, Transgenicen_US
dc.subject.meshMolecular Sequence Dataen_US
dc.subject.meshPolymorphism, Single-Stranded Conformationalen_US
dc.subject.meshReceptors, Antigen, T-Cellen_US
dc.subject.meshReverse Transcriptase Polymerase Chain Reactionen_US
dc.subject.meshT-Lymphocytes, Regulatoryen_US
dc.titleIntratumoral Convergence of the TCR Repertoires of Effector and Foxp3+ CD4+ T cellsen_US
dc.typeArticleen_US
dc.identifier.pmcidPMC2964305en_US
dc.contributor.corporatenameCenter for Biotechnology and Genomic Medicine-
dc.contributor.corporatenameDepartment of Biostatistics and Epidemiology-
dc.contributor.corporatenameGHSU Cancer Center-

Related articles on PubMed

All Items in Scholarly Commons are protected by copyright, with all rights reserved, unless otherwise indicated.